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Abbreviations 
Ip Isoelectric point value 
STR Stirred bioreactor 
PFR Loop acting as an approximate plug flow reactor 
FC Flow cytometer  
HC Haemocytometer  
VCN Viable cell number  
DCN Dead cell number  
sub Proprietary glucose feed as substrate 
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Bullet points 
 
• Repeatable fed batch cultivation of three different CHO cells is reported  
 
• Recirculating CHO cells and media by peristaltic pump lowered process performance 
 
• High laminar extensional energy dissipation rates did not lower process performance 
 
• Neither did stirring with Rushton turbines at specific powers 50 times typical  
 
• Protein quality was not affected under any of these operating conditions  
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Abstract.  
Two series of reproducible fed-batch bench scale cultures have been undertaken, one 
series simulating the impact of spatial variations in pH and nutrients as found at commercial 
scale on performance, the other, the impact of fluid dynamic stresses associated with 
agitation. The first was unsuccessful because, somewhat surprisingly, the use of a peristaltic 
pump to circulate cells and medium through different spatial environments always led to a 
similar reduction in culture time and resulting product titre compared to uncirculated 
controls. This fall was sufficient to essentially mask other effects. In the second, even at 
maximum specific energy dissipation rates up to ~ 160 times > with laminar extensional flow 
and ~ 25 times > with turbulent flow compared to typical commercial conditions, no 
significant effects were observed on cell growth and viability. Most importantly, in all of the 
cases studied, product quality was unaffected compared to controls. In addition, it is suggested that 
because of the possibility of cell line specific behavior and the relationship between damage 
to entities and the Kolmogorov scale of turbulence, sensitivity to fluid dynamic stresses is 
best studied in turbulent bench scale bioreactors.   
 
 
Keywords: CHO cells, mechanical stress, environmental stress, product quality, process 
performance. 
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1. INTRODUCTION  
 
Freely suspended animal cells have been grown commercially in agitated, stainless 
steel bioreactors since at least 1965 (Telling and Elsworth, 1965) when it was reported that 
one of 30 L was being used for the production of inactivated foot and mouth disease vaccine 
from BHK cells; and similar bioreactors were built at the 8 m3 scale at around the same time 
for the production of interferon from Namalwa cells (Pullen et al., 1985). More recently, 
bioreactors of 20 m3 or so have been installed at Lonza and Genentech (Nienow, 2006). In 
spite of these successes, since the beginning, there has been concern that because animal cells 
lack a cell wall, they were very prone to damage due to turbulent fluid dynamic stresses 
(often called shear ‘sensitivity’), particularly due to impeller agitation and this concern was 
discussed in depth in a review (Nienow, 2006), In particular, it was shown that whilst the 
oxygen transfer requirements of the cells could be met by agitation intensities (expressed as 
mean specific energy dissipation rate, Tε W/m
3) of the order 10 to 20 W/m3 (the latter being 
used for comparison here), a wide variety of cells grew to the same cell density when 
subjected to Tε values up to 250 W/m
3.  
It was also shown that this perception of fragile cells had led to problems because the 
low agitation intensity could lead to poor spatial and temporal homogeneity. The latter was 
especially poor with respect to pH close to the surface of the medium where base for control 
was added (Langheinrich and Nienow, 1999) and an experimental scale-down model (Osman 
et al., 2002) indicated that this pH deviation could lead to a significant reduction in viable 
cell density when growing GS-NSO cells. Work with bacteria has also shown a poorer 
performance on scale-up due to inhomogeneities associated with nutrient addition in fed-
batch fermentations and with pH control chemicals due to surface addition (Hewitt and 
Nienow, 2007).  
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 In spite of the earlier studies, the perception of cell fragility remains and recently, 
concern has been expressed that though cell viability may not be compromised at higher 
Tε values, product quality, especially glycosolation, may be. To further explore such issues, 
Chalmers and co-workers (Godoy-Silva et al., 2009a, 2009b) have recirculated cells though a 
flow device in which cells are subjected to a converging, mainly extensional, flow at very 
high local laminar specific energy dissipation rates, Lε W/m
3. Their justification for the very 
high values utilized was that in a stirred bioreactor the maximum local turbulent specific 
energy dissipation rate, which is found very close to the impeller, is much greater than the 
average, i. e. TT εε >>max)( . They assumed that TT εε 100)( max = ; and that, more importantly, 
high specific energy dissipation rates in turbulent and laminar flow should produce the same 
(or a similar) impact on cells during cell culture. Using Lε  values of the order of 10
6 W/m3 
with two different cell lines, they found a reduction in performance compared to that found at 
standard conditions ( max)( Tε around 2.5 x 10
4 W/m3 based on the 
assumption TT εε 100)( max = ). However, in the first case, cell growth was inferior compared to 
controls without recirculation (Godoy-Silva et al., 2009a); and in the second, it was product 
quality (Godoy-Silva et al., 2009b).  
 The work reported covers two projects with different objectives. However, they are 
brought together here because one of the findings in both studies was surprising; and at the 
same time, important for gaining further insight into the robustness of animal cells and their 
products under different processing conditions. One was undertaken at the University of 
Birmingham and aimed to investigate the impact of environmental stress on cells due to local 
high pH and glucose levels arising from surface feeding during large scale fed batch culture. 
In this study, a CHO cell line from MedImmune was used; and MedImmune also assessed 
the quality of the protein product. The technique used was based on one that had been used 
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successfully when applied to microbial systems (Hewitt and Nienow, 2007). In this 
technique, first introduced by Enfors and co-workers (Larsson and Enfors; 1988), the 
medium and cells are circulated through a plug flow loop with a frequency similar to the 
average with which they circulate due to agitation at the large scale, The volume of the loop 
is chosen to match the size of the zone (relative to the total volume in the stirred bioreactor) 
where high concentrations of nutrients or pH control chemicals are found when feeding to the 
top surface of the large scale bioreactor, as is common practice.   
 The other study was undertaken later at Genentech using the laminar extensional flow 
device developed by Chalmers (Ma et al., 2002). The aim was to clarify the earlier work of 
Godoy-Silva et al. (2009a; 2009b) on the impact of laminar stresses on process performance 
and product quality using two Genentech production CHO cells lines. In addition, further 
studies with these two lines were conducted in a bioreactor agitated by dual Rushton turbines 
at turbulent mean specific energy rates, Tε up to 1000 W/m
3. In studies, cell growth, product 
titre and antibody quality were all assessed.  
2. EXPERIMENTAL 
3L and 2L working volume, fed-batch, bench scale stirred bioreactors (STRs) were 
used to cultivate CHO cells producing an IgG antibody with pH and dO2 control; the first for 
the stresses associated with inhomogeneities due to glucose and pH and the second for the 
mechanical stress study respectively. Firstly, duplicate primary control runs were undertaken 
where cells were cultured in the bioreactor using standard conditions including low turbulent 
specific mean energy dissipation rates, ( Tε  = ~ 20 W/m
3). Secondly, duplicate runs were 
undertaken where each bioreactor was operated as in the primary control but cells and 
medium were taken from it and circulated through a loop, either by a peristaltic pump for 
both stress conditions; or by syringe pump for the mechanical stress study. In the secondary 
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control runs for investigating the stress due to inhomogeneities due to nutrients or pH, 
circulation was undertaken without any additions into the loop. Subsequently, for the actual 
investigation of homogeneities, duplicate runs were undertaken where additions were made 
into the loop (Fig. 1). For the secondary control for the mechanical stress study, the laminar 
extensional flow device was not included in the loop whilst for the actual investigation, it 
was. In both cases, circulation was only begun at day 4 to ensure that both cultures started in 
a similar fashion.  
For the primary and secondary controls in the inhomogeneity study used a defined 
medium, including Pluronic F68 (Sigma-Aldrich, UK), with a temperature of 36.5 °C, the 
dO2 being held at 30% using a fixed agitation speed and variable air flow rate. Sodium 
bicarbonate buffer (pH 9.7) and sparged CO2 were introduced directly into the bioreactor on 
demand in order to control the pH in the bioreactor at 6.95. A proprietary glucose supplement 
(pH 2.5) was also introduced into it using exponential feeding, starting when either the viable 
cell number (VCN) had reached 1 x 106 cells/mL (measured by haemocytometer and Trypan 
Blue exclusion and/or flow cytometric analysis using a Coulter Epics Elite Analyser 
(Beckman Coulter, UK)) or after day 4 from inoculation of the STR, whichever occurred 
first. In this way, the concentration of glucose in the bioreactor was maintained at 4.5 g/L ± 
1.5 g/L. For the actual inhomogeneity studies, the aim was to maintain similar conditions in 
the bioreactor but either the sodium bicarbonate buffer or both it and the glucose supplement 
were introduced into the loop (PFR). The volume of the PFR (made of neoprene) mimicked 
the proportion of a commercial bioreactor (~ 5%) occupied by the feed plume as assessed by 
flow visualisation (Langheinrich and Nienow, 1999) and also used in earlier studies on the 
impact of feed zone inhomogeneities (Namdev and Thompson, 1992; Amanullah et al., 2001). 
Two rates of circulation through the loop were used, generated by a Watson Marlow 505 S 
peristaltic pump, to bracket the range of circulation times found at the low agitation  
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intensities used at the 20 m3 scale to give mean residence times of 60 s (flow rate 150 
mL/min) and 120 s (flow rate 75 mL/min) (Hewitt and Nienow, 2007). In addition, an 
experiment was undertaken in which the concentration of bicarbonate was increased a 100 
fold to 2M to give pH 12.3, as often very concentrated feeds are used in order to minimise 
storage volumes, excessive culture dilution and sterilisation costs. The duplicate runs 
undertaken are summarised in Table 1 based on the mean residence time in the loop and 
where the additions were made.  
Three standard methods as employed by MedImmune were used to assess the effects 
of the various conditions imposed on the quality of the IgG protein: mass analysis using 
liquid phase chromatography (LC) followed by electrospray ionisation (ESI) coupled to a 
quadrapole time-of-flight (TOF) mass analyser, referred to as ESI-Q-TOF (Zhang et al., 
2009); charge analysis using isoelectric focusing (IEF); glycoform profiling using normal 
phase high pressure liquid chromatography (NP-HPLC) using 2-aminobenzamide (2-AB) as 
the fluorescent tag, referred to as NP-HPLC 2-AB (Guile et al., 1996).  
For the mechanical stress study, the cultures used a serum-free medium based on 
DMEM/F12 supplemented with 1 g/L Pluronic F68, recombinant human insulin and 
hydrolyzed protein (peptone) with dO2 controlled at 30% and pH at 7.15. The loop was 
essentially as described earlier (Godoy-Silva et al., 2009a; 2009b) with a 3.1 mm diameter 
Pharmed BPT tubing (Cole Parmer, Vernon Hills, IL) plus the extensional flow device with 
constrictions of 227 µm and 762 µm at a flow rate to give Lε values of 2.9 x 10
5 W/m3 and 
1.9 x 103 W/m3 respectively. The two pumps utilized were a Cole Parmer peristaltic pump 
and a Pump 33, Harvard Apparatus dual syringe pump. In addition, a run was undertaken 
with one bioreactor as control and another one with dual Rushton turbines giving rise to a 
mean specific energy dissipation rates, Tε  after day 4 of either 360 W/m
3 or 1000 W/m3. The 
antibody product quality was assessed using a Genentech protocol in a similar set of ways to 
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that set out above. It should be noted that with the techniques employed to assess quality, it 
would be difficult to detect any changes in charge profiles associated with sialylation. 
However, since sialylation was not present in the antibodies produced from any of the cell 
lines used in this study, that limitation was not important. 
Further details of the medium and the fed-batch and other operating conditions in the 
bioreactor are given elsewhere: for the pH and nutrient study (Scott, 2011) and mechanical 
stress study (Chaderjian et al., 2005).   
3. RESULTS AND DISCUSSION 
3.1 Impact of stresses generated by pH and glucose excursions 
 In the two primary control runs without circulation through the loop, the fed batch 
culture ran for 18 days producing an average maximum cell density of ~ 8.5 x 106 cells/mL 
(Fig. 2 and Table 2). Figure 3 shows the growth curves with cell viability, viable cell number 
and dead cells for all the runs conducted with the circulation loop in place. In Fig 3a to Fig 
3d, in each case, the data obtained from the two runs with the loop in place but with addition 
of nutrients and pH control chemicals into the stirred bioreactor; are compared with that 
found with the duplicate runs related to one of the four scale down scenarios, simulating loss 
of homogeneity at the large scale.  
A comparison of Fig 2 and 3 along with the data in Table 2 shows that though the 
maximum viable cell number varied from run to run, there was no consistent pattern with 
respect to the primary control, secondary control (with recirculation but with feed into the 
bioreactor) or the runs with feed into the loop. On the other hand, as can be seen, the 
maximum was reached earlier with the loop in place and that is also suggested by the higher 
growth rates (µmax) for these runs shown in Table 2. In addition, for all runs with 
recirculation, at the end of the exponential phase, viability began to drop significantly 24 h 
after the maximum viable cell number was attained and they were all characterised by a 
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shallow decline in cell viability from the end of exponential growth phase that contrasted 
with the primary control which exhibited an abrupt decline in cell viability only after a 
stationary phase with viability maintained above 90%. As a result, the duration of all the 
cultures with recirculation was 428 ± 18 h (mean ± standard deviation, N = 10) compared to 
508 ±  45 h (mean± standard deviation, N = 2) for the primary control without recirculation. 
Inspection of Fig 3 might suggest that the duration of the runs with recirculation and feed 
into the loop was a little shorter than the secondary control; but the standard deviation on the 
different runs suggests that any difference is within the scatter of the data. Further insight is 
difficult because culture duration refers to the time when cell viability fell below 30%, a 
value often reached between samples which were taken every 24 h. Certainly, there is not 
any indication that with increasing potential stress (increased residence time in the loop or 
increasing pH of the addition), a particular trend in the results is indicted. Given the 
similarity of the results, Fig 4 compares the two control runs without recirculation, with the 
10 runs with circulation pooled together. As can be seen, the error bars on the two control 
runs are similar to those on all the runs with recirculation. 
Fig 5 compares the IgG antibody titre using the data for each of the two secondary 
control runs without recirculation with the data from all the ten runs with continuous 
recirculation through the PFR whether addition was made into the STR or the PFR. As can 
be seen, the mean results are very different and the error bars are very small for both data 
sets. Table 2 also summarises the maximum antibody production rate per cell and the overall 
titre for all the different runs. It again indicates that though there is a fall in maximum 
antibody production rate per cell and overall titre of ~ 25% and ~ 20% respectively with 
recirculation, it is not possible to detect a trend with increasing stress from additions in the 
loop.  
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On the other hand, in spite of the changes in process performance as a result of 
recirculation through the loop, the protein quality (mass and charge heterogeneity and 
glycosolation pattern) was essentially the same for all cases with or without recirculation. For 
example, Table 3 compares the isoelectric point band values (Ip) from the isoelectric focusing 
analysis of purified antibody at harvest from the different experimental scale-down conditions 
and a comparison of the mean values with that of the secondary (PFR) scale down (ΔIp 
control). Charge heterogeneity is primarily introduced by deamidation and C-terminal lysine 
micro-heterogeneity (Tsai et al., 1993; Perkins et al., 2000). However, the antibody studied 
here was missing a C-terminal lysine. Therefore, any change in charge has to be attributed to 
deamidation, which introduces an additional negative charge to the antibody and generates 
acidic species, decreasing the protein’s isoelectric point (Liu et al., 2008). These factors have 
been found sensitive to process condition (Jenkins, 2007) and the isoelectric point might 
reasonably be expected to have fallen after repeated exposure to elevated osmolality and pH 
during alkali addition to the PFR. Yet, the variation in mean isoelectric point across the various 
experimental conditions in Table 3 is insignificant, the difference between the mean Ip of each 
run and the control mean (here called ΔIp control) being within the expected error range for 
the technique as experienced at MedImmune.   
Another example is shown in Fig 6 where the glycoform patterns are compared. 
Consistency of glycoform is a major consideration when assessing protein quality for 
therapeutic purposes (Jenkins, 2007; Godoy-Silva et al., 2009a; 2009b).  As can be seen, the 
small variation in glycoforms between the differing experimental conditions to which the 
cells were exposed is quite random and typical of that found in industrial historical data. The 
same conclusion could be drawn from the other assessments of protein quality (data not 
shown), namely that there was not any significant difference in antibody quality between all 
the conditions investigated.  
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 Thus, though this scale-down technique has provided much insight with bacteria, 
unfortunately, it was not possible to conclude anything concerning the impact of bioreactor 
heterogeneities with this cell line. It appears that with these CHO cells, the use of the 
peristaltic pump itself induced the changes in growth and productivity; but did not impact on 
product quality.                                    
3.2 Impact of fluid dynamic stresses 
 Two Genentech cell lines were used, one of which (Cell A) was less robust than the 
other (Cell B), based on their exposure to a single passage through the laminar extensional 
flow device at Lε  values of 1.1 x 10
8 W m-3 which had previously been shown to be lethal to 
cells (Mollet et al., 2007). In all cases, when recirculation was used, it was only begun on day 
4 to check that cells were growing within the parameters expected from historical data.    
3.2.1 Recirculation with the peristaltic pump.  
Primary control and secondary control runs were initially conducted as described 
above before runs with the device in place were then undertaken. Figure 7a shows the results 
for cell growth and titre (normalized for commercial confidentiality) for the more robust cell 
B for the primary control and secondary control. As can be clearly seen,,the data for 
secondary control without the device (when there should not have been any increased stress) 
indicates a much lower maximum viable cell count, % viability and titre. In addition, the 
results with the runs with the different devices in place were very inconsistent (data not 
shown). At this time, the problems associated with recirculation by peristaltic pump 
discussed above in the other experimental study were becoming clear. However, 
interestingly, as in the above study, the protein quality (assessed using the same experimental 
criteria as discussed below when using the syringe pump) (data not shown)) were statistically 
the same for all the runs with the peristaltic pump. 
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Overall, it was decided to try circulation with a syringe pump as was used in the 
previous work by Godoy-Silva et al., (2009a; 2009b) when using the extensional flow device. 
All further runs related to mechanical stress were undertaken this way.  
3.2.2 Recirculation with the syringe pump.  
These experiments were conducted in the same way as those with the peristaltic 
pump. However, in this case, the growth curves with the primary and secondary control were 
very similar (see Fig 7b for cell B). In addition, whether the 227 or 762 µm device was used 
giving Lε values of 2.9 x 10
5 W/m3 and 1.9 x 103 W/m3 respectively, the performance with 
respect to growth and titre was the same as the two controls for both cell lines. Figure 8 
shows the results for the more robust cell B at 2.9 x 105 W/m3. Essentially, the equivalent 
results were found for each extensional flow device with each cell line (data not shown).  
3.2.3 Agitation with dual Rushton turbines. 
Two runs were undertaken to give mean specific energy dissipation rates, Tε  of either 
360 W/m3 or 1000 W/m3. Assuming, as explained earlier that TT εε 100)( max = , then when 
using two impellers, maximum turbulent specific energy in this run was 1.8 x 104 W/m3 or 
5.0 x 104 W/m3. Thus, whilst the mean values were extremely high compared to that 
normally used commercially for growing cells ( ~ 20 W/m3) (Nienow, 2006), the maximum 
is still less than that used in the elongational flow device under laminar conditions. However, 
though there was a difference between cell lines, the growth and productivity in the Rushton 
turbine studies was overall in the same range with as that found with both of the devices, 
with small differences between the control runs and those with the Rushton turbines but 
without a specific trend (data not shown).  
3.2.4 Product quality.  
Representative product quality data are shown in Fig 9 for cell B for all the 
configurations and different stress levels studied. Fig 9a shows the % of the different 
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glycoforms whilst in Figs 9b   the percentage of monomeric mAB is shown. The 
measurement of charge variants quantifies the acidic, main and basic peaks and in Fig 9c, the 
results for the main peak are shown. As can be clearly seen, the values for each quality 
characteristic are consistent for each technique (as were the values for the other charge peaks 
(data not shown)) over the wide range of stresses employed. Though the absolute values were 
different, the consistency across the various experiments was very similar for cell A (data not 
shown).                          
3.2.5 Implications for Commercial Cell Culture.  
 
The consistency with which culture performance at these high stress levels gives 
results similar to each other and to historical data is contrary to those obtained earlier 
(Godoy-Silva et al., 2009a; 2009b), which suggests cell line specificity. However, the really 
important point is this: are any cells (or their product quality) likely to be affected by the 
values of max)( Tε required to operate cell culture bioreactors successfully, recognizing that the 
levels of Tε used in this work are up to  ~ 50 times greater than those currently required? 
Even allowing for the increased cell density that will probably to be achieved in future and 
therefore requiring a higher Tε  to satisfy the increased oxygen demand, there is a 
considerable margin available before the levels tested here are reached. 
3.2.6 The Suitability of Extensional Flow for Turbulent Stress Studies.  
The impact of turbulent stresses on entities suspended within it is usually assessed by 
comparing the size of the entity with the Kolmogorov microscale of turbulence, Kλ at the 
maximum specific energy dissipation rate in a stirred bioreactor; 
4/1
max
23 ))(/( TK ερµλ =    1 
whereµ (Pas) is the viscosity and ρ (kg/m3) is the density. If the size of the entity is < Kλ , it 
should not be damaged. There are difficulties in applying this concept because values of 
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max)( Tε are only available for a few impellers and when they are, the range of values obtained 
by different workers is large. Nevertheless, such approaches have worked well for many 
single cell biological entities (bacteria, yeast, animal cells (Nienow, 2006; Hewitt and 
Nienow, 2007)) as well as for drop breakage in liquid-liquid systems. Indeed, for analysis of 
the latter topic, completely different theories are applied for turbulent and laminar flow; and 
under laminar flow conditions, drop breakage occurs under some conditions in extensional 
flow when it would not for shear flow (Leng and Calabrese, 2004). In addition, for a given 
geometry, the spatial distribution of turbulent specific energy dissipation rate (even if 
max)( Tε is not known precisely) is independent of reactor scale, as is Equ 1. Therefore, it is 
recommended that cell-sensitivity to mechanical stress during cultivation is studied in 
turbulent stirred bench scale bioreactors for scale-up purposes rather than other 
configurations. 
3.3 An Overall Perspective from Both Studies 
Given the poorer process performance when using the peristaltic pump to recirculate 
cells in both studies, it is interesting to consider other reports in the literature which might 
throw some light on the impact of pumping/recirculation on animal cell culture. Perfusion 
culture has been frequently studied and often involves the use of pumps to recirculate the 
cells. Pump damage was found to reduce the viability of a variety of animal cell types, 
including insect (Merten, 2000; Gorenflo et al., 2004), hybridoma (LaPorte et al., 1996) and 
CHO cells (Kim et al., 2008). Yet, in perfusion culture, the rate of pumping is far lower than 
here, circulation rates being about 1 to 10 bioreactor volumes/day (Merten, 2000; Kim et al., 
2008) compared to ~ 100 to ~ 200 per day here.  
 It is also relevant to consider the impact of peristaltic pumps on other biological 
entities. In studies of the continuous pumping of blood cells for cardiopulmonary bypass 
operations, peristaltic pumping has been cited as a cause of lysis and cumulative sub-lethal 
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damage generally attributed to compression of the tubing as the pump rollers rotate (Sutera, 
1977; Watanabe et al., 2006). Using computational fluid dynamics to model a two roller 
pump, Mulholland et al. (2005) showed a sharp peak in laminar shear stress of almost 1000 
Pa when the rollers are almost closing the tube. Experiments by Born et al. (1992) indicated 
lethal damage to suspended animal cells during laminar flow at shear stresses < 100 Pa. On 
the other hand, Jaspe and Hagen (2006) found shear stresses > 104 Pa were required to 
denature proteins whilst others (Bee et al., 2009) have concluded that antibodies cannot be 
damaged by fluid dynamic stresses without additional interfacial effects too. Similar results 
have been reported on other protiens since at least 1979 (see, for example, Thomas et al. 
(1979)).  
 Overall, from the literature, it can be concluded that sub-lethal damage to the CHO 
cells cultivated in this work due to their passage through a peristaltic pump is not an 
unrealistic explanation for the deterioration in process performance found under those 
conditions. There is also evidence in the literature over many years that fluid dynamic 
stresses alone should not damage proteins. Such reports support the other generic finding of 
these two studies. Whether there is sub-lethal damage to the CHO cells with the peristaltic 
pumps; or the cells are exposed to very high energy dissipation rates in laminar extensional 
flows in the loop or turbulent flows in the bioreactor, the IgG antibody quality is unaffected. 
4. CONCLUSIONS 
 Two fed-batch studies cultivating CHO cells have been undertaken. In the first on pH 
and nutrient excursions associated with the simulation of poor homogeneity found on scale 
up, the method employed was not successful. It failed because it required cells to be 
circulated for the duration of the culture by peristaltic pump, which in each case led to a 
reduction in culture time and a concomitant fall in product titre compared to the control 
without recirculation. In the second, cells were subjected to elevated fluid dynamic stresses 
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either by recirculating them through a laminar converging flow device or in the turbulent 
flow generated in a bioreactor agitated by a Rushton turbine. In this case, cell density and 
product titre were not affected by the stress whatever the type of flow or level imposed. Very 
importantly, in every case studied, the IgG product quality was the same as the control 
regardless of the stress imposed.  
It is still not possible to explain the reason for the difference between the current 
findings and those of Godoy-Silva et al. (2009a; 2009b). A possible one is cell line specific 
behaviour. If that is the case, it is crucial to have a reliable scale down test for the assessment 
of cell robustness as new cell lines are introduced.  Since turbulent flow is the universal 
condition in large scale animal culture bioreactors and there is a well-established relationship 
between damage to entities and the Kolmogorov scale of turbulence, independent of scale, it 
is suggested that sensitivity to fluid dynamic stresses is best studied in turbulent bench scale 
bioreactors.   
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6. NOMENCLATURE AND UNITS 
Lε   Laminar specific energy dissipation rate, W/m
3 
Tε   Turbulent local specific energy dissipation rate, W/m
3 
max)( Tε  Maximum turbulent local specific energy dissipation rate, W/m
3. 
Tε   Mean turbulent specific energy dissipation rate, W/m
3. 
Kλ   Kolmogorov length scale, m 
 
µ   Dynamic viscosity, Pa s 
ρ   Density, kg/m3 
τR   Mean residence time in the loop 
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Figures 
 
Figure 1: Schematic of the secondary control experiment with a plug flow reactor (PFR) and 
of scale-down test runs where recirculation by peristaltic pump was continuous for both 
cases. In the secondary control, additions are made only to the stirred tank reactor (STR). In 
the scale-down runs, additions were made to the PFR as described in Table 1.  
 
Figure 2 Growth curves for the fed-batch primary control for the homogeneity study:        
Comparison of flow cytometer (FC) and haemocytometer data (HC) (viable cell number 
(VCN) (cells/mL), dead cell number (DCN) (cells/mL) and viability (%)). (Each point is the 
average of duplicate experiments; error bars represent the data range). 
 
Figure 3 Growth curves from all runs with recirculation based on haemocytometer data; 
Open symbols for secondary control (addition into the stirred bioreactor), closed for scale 
down simulations by addition into PFR (the same secondary control data are shown in each 
figure); (viable cell number (cells/mL), squares; dead cell number (cells/mL), triangles; 
viability (%), circles): a) pH chemicals addition, mean residence time, τR = 60 s; b) pH 
chemicals and glucose supplement addition, τR = 60 s; c) pH chemicals and glucose 
supplement,addition, τR = 120 s; d) pH chemicals (x 100 concentration) and glucose 
supplement,addition, τR = 120 s. 
 
Figure 4 Comparison of growth curves from primary control experiments without continuous 
recirculation (closed) with all those with continuous recirculation (open) based on haemocytometer 
data: (viable cell number (cells/mL), squares; dead cell number (cells/mL), triangles; viability 
(%), circles). Each point is the mean and error bars are 1 standard deviation. (Experiments with 
recirculation, N = 10; without recirculation, N = 2).  
 
Figure 5 IgG antibody titre for runs with (open points) and without (closed points) 
continuous recirculation through the PFR. (Each time point is the mean and error bars are 1 
standard deviation: tests with recirculation, N = 10, tests without, N = 2). 
 
 Figure 6 Mean relative % of each glycoform on the IgG antibody for each pair of duplicate 
experiments at the end of the fed-batch process: primary control (dots); secondary control 
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(black); pH, 60 s (narrow forward slash); pH and substrate, 60 s (wide forward slash); pH and 
substrate, 120 s (narrow back slash); pH (x100) and substrate, 120 s (wide back slash). 
 
Figure 7 Growth curves for the lower sensitivity cell B: a) Primary control (open symbols, 
n=7) and secondary control with recirculation by peristaltic pump (closed symbols, n = 3); b) 
Primary control (open symbols, n=7) and secondary control with recirculation by syringe 
pump (closed symbols, n = 7).. (Squares, viability; diamonds, viable cells; triangles, titre; the 
error bars indicate one standard deviation, dashed line at day 4 indicates when recirculation). 
was started  
 
Figure 8 Cell B: Recirculation from day 4 (indicated by dotted line) by syringe pump without 
the device (secondary control-open symbols, n=2) and with 272 µm device (closed symbols, 
n = 2) to give Lε  of 2.9 x 10
5 W/m3. (Squares, viability; diamonds, viable cells; triangles, 
titre; the error bars indicate one standard deviation). 
 
Figure 9 Cell B: Product quality for all the different operating conditions with recirculation 
using the syringe pump and the elongational flow device; and with the Rushton turbines: a) 
glycoform profiles; b) mAb % monomer; and c) charge variant (% main peak). 
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Tables  
Table 1 Description of experimental protocol for the inhomogeneity study. 
 
Table 2 Growth and productivity data for each condition studied: maximum specific growth 
rate (µmax), maximum viable cell number (VCNmax), maximum specific rate of antibody 
productivity (q IgGmax); harvest antibody titre (IgG titre) (In this Table, ‘60s’ and ‘120s’ refer 
to the residence time of the recirculated medium and cells in the PFR; and ‘sub’ and ‘pH’ 
refer to the glucose supplement and pH chemicals respectively that were added into the 
PFR). 
 
Table 3 The six isoelectric point band values and their mean from a scan of the gel plate (not 
shown) produced during isoelectric focusing analysis of samples of purified antibody at 
harvest from each of the two control experiments and of the four simulated scale-down 
experimental conditions; and the means (mean Ip) are compared with the secondary control 
experiment (ΔIp control = Ip for the particular run minus Ip for the secondary control). 
 
Tables  
Experiments Simulating a 20 m3 Bioreactor                             Each run done in duplicate 
• Control 1; No recirculation, Fed batch STR without PFR 
τR = 60s 
• Control 2; Recirculation through STR + PFR feeding alkali and substrate 
into STR 
• Recirculation through STR + PFR with substrate fed to the STR and 
alkali (pH 9.7) to the PFR (≡ surface feed) 
• Recirculation through STR + PFR with substrate and alkali fed to the 
PFR (≡ surface feed for both) 
τR = 120s 
• Recirculation through STR + PFR with substrate and alkali fed to the PFR (≡ 
surface feed for both) 
• Recirculation through STR + PFR with substrate and alkali (x 100 higher 
concentration, pH 12.3) fed to the PFR (≡ surface feed for both)                
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(τR fixed by flow rate from the peristaltic pump) 
 
Table 1 
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Experimental Case µmax VCNmax qIgGmax Titre 
  (h-1) 105 cells/mL pg/cell/h mg/L 
Primary control fed-batch STR  0.026 78 1.48 1003 
Primary control fed-batch STR 0.025 89 1.65 1031 
Secondary control (PFR in place)  0.027 86 1.04 786 
Secondary control (PFR in place)  0.037 84 1.18 811 
pH (60 s)  0.026 94 1.14 776 
pH (60 s)  0.031 81 1.44 752 
pH & sub (60 s)  0.028 75 1.02 791 
pH & sub (60 s)  0.033 77 0.97 729 
pH & sub (120 s) 0.027 82 1.26 804 
pH & sub 120 s) 0.033 82 1.26 784 
pH (100x) & sub (120 s)   0.030 80 1.29 841 
pH (100x) & sub (120 s)   0.028 80 1.31 819 
 
Table 2  
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Experim
ent 
.Primary 
control. 
Secondary 
Cont. 
pH, 
60s. 
pH & 
substrate, 60s. 
pH & substrate, 
120s. 
pH (x 100) & 
substrate, 120s 
 6.72 6.70 6.66 6.61 6.63 6.61 
 6.60 6.57 6.54 6.49 6.49 6.48 
 6.50 6.47 6.45 6.42 6.41 6.40 
 6.46 6.43 6.40 6.36 6.36 6.35 
 6.42 6.38 6.36 6.34 6.30 6.29 
 6.37 6.32 6.30 6.26 6.24 6.23 
Mean Ip 6.51 6.48 6.45 6.41 6.41 6.39 
ΔIp 
Control 0.03 n/a -0.03 -0.06 -0.07 -0.08 
 
Table 3  
Figures 
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